cmx-001 has been researched along with African-Swine-Fever* in 1 studies
1 other study(ies) available for cmx-001 and African-Swine-Fever
Article | Year |
---|---|
Brincidofovir is a robust replication inhibitor against African swine fever virus
African swine fever virus (ASFV) infection is a major public and socioeconomic concern that has a serious impact on the global swine industry. Unfortunately, there are currently no commercially available vaccines or antiviral agents that are both safe and effective against ASFV. In the study, we use primary porcine alveolar macrophages to screen a kinase inhibitor library for anti-ASFV compounds. Six candidate compounds that inhibited ASFV infection with inhibition of > 90% were identified, among which brincidofovir exhibited optimal inhibitory effects on ASFV. Brincidofovir reduces ASFV replication in a dose-dependent manner (IC Topics: African Swine Fever; African Swine Fever Virus; Animals; Swine; Virus Replication | 2023 |